Life-sciences consulting & pre-seed investment

Science-driven biomanufacturing,
from concept to capital.

BiOversiz partners with pharma and biotech innovators to advance next-generation biologics — vaccines, mRNA therapeutics, antibodies and nanobodies — through rigorous consulting and early-stage investment.

Who we are

A science-led partner for the future of biologics

BiOversiz brings together scientific depth and entrepreneurial drive. We help pharmaceutical and biotech companies — as well as governments, NGOs and research institutions — implement more innovative and effective strategies across the biomanufacturing value chain.

From the earliest research to the first round of funding, we work hand in hand with founders and teams to turn promising science into platforms that are credible, manufacturable and ready to scale.

3Core activities
mRNAVaccines & therapeutics
(Pre)SeedEarly-stage capital
BiologicsAntibodies & nanobodies

What we do

Three ways we move biologics forward

From the first line of code to the first round of funding, we help science-led teams build platforms that are innovative, manufacturable and ready to scale.

Research & Development

We advance biomanufacturing from the ground up — bioinformatics, artificial intelligence and process design — turning early science into scalable platforms.

Learn more

Consulting

Science-driven strategy for biotech and pharma: clear business plans, regulatory pathways and go-to-market strategies for early-stage companies.

Learn more

Investment

Pre-seed capital for bold ideas. We back promising biotech and tech startups with funding plus hands-on expertise to build a minimum viable product.

Learn more

Let’s build the future of biologics together.

Whether you’re a pharma company seeking a science-led partner, or a co-investor looking for the next breakthrough, we’d like to hear from you.